TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CDNA

CareDx Inc

Healthcare · Diagnostics & Research

61.40$ +13.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

CareDx Inc (CDNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 533 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CDNA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
102 77 80 78 75 84 79 80 91 131 128 143 145 152 157 345 354 369 541 557 563 567 547 541 545 543 528 515 501 467 452 467 477 491 490 444 432 413 411 533
35 27 23 20 17 27 33 31 42 81 78 68 68 72 66 252 259 273 439 441 445 433 411 404 388 388 371 361 345 314 303 321 334 352 350 307 300 257 269 429
22 17 12 9.1 6.0 17 19 16 26 65 57 43 41 38 32 211 214 135 309 336 353 348 172 167 83 90 75 88 76 82 93 96 95 115 89 68 91 65 78 374
22 17 12 9.1 6.0 17 19 16 26 65 57 43 41 38 32 211 214 225 374 370 363 348 319 306 291 293 286 283 268 235 216 229 241 261 231 186 194 177 187 374
4.6 2.8 3.4 3.0 3.3 3.0 6.5 8.1 9.6 9.8 13 17 19 24 23 27 31 35 43 48 56 60 65 70 70 66 59 52 52 51 60 66 67 65 71 67 48 43 45 34
7.4 5.5 6.0 6.3 6.2 5.5 5.0 4.7 4.6 4.9 5.2 5.3 5.9 6.0 6.9 8.7 9.9 10 14 15 19 17 18 19 18 19 18 19 18 19 20 19 19 20 23 28 28 27 26 7.0
3.3 2.9 2.8 2.5 2.3 2.1 2.1 2.4 3.0 4.1 3.8 3.5 3.7 9.2 5.5 7.3 10 26 11 32 37 40 45 49 70 70 – 68 – – – – – – – – – – – –
28 14 12 12 12 12 12 12 12 12 12 23 24 24 24 24 24 24 26 26 26 37 37 37 38 38 40 40 40 40 40 40 40 40 40 40 40 40 40 36
35 33 33 34 34 33 32 35 34 33 32 46 46 46 43 44 44 44 45 48 48 50 48 46 44 43 46 44 46 46 43 42 40 38 37 36 33 32 32 19
65 57 65 66 75 90 46 51 47 35 32 50 47 53 55 84 85 91 70 78 91 101 89 98 108 112 108 110 107 205 196 202 204 113 110 117 121 110 98 107
40 41 53 54 31 43 13 14 16 20 16 29 31 35 28 57 62 69 46 56 70 77 67 78 70 76 72 74 73 78 70 78 81 89 85 93 99 90 79 94
18 23 32 34 15 16 0.5 0.1 0.2 0.2 2.0 2.0 2.0 3.0 1.6 1.7 1.9 2.0 3.1 3.4 3.8 4.0 3.7 3.0 5.2 5.6 5.7 5.8 6.0 5.9 6.1 6.1 6.1 6.1 6.2 6.3 6.4 6.5 6.7 6.0
3.5 12 3.5 3.6 3.4 3.4 4.3 3.5 2.7 4.7 3.9 7.4 5.7 5.5 6.6 8.7 9.5 9.7 12 13 15 13 11 17 11 9.9 13 9.9 9.0 13 10.0 5.9 6.2 7.7 8.1 9.9 12 10.0 9.1 9.5
8.5 1.1 0.0 0.0 21 18 9.7 13 13 – 2.3 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
36 19 15 12 -0.3 -6.1 33 29 44 96 96 93 98 99 101 261 269 278 472 480 472 466 458 444 437 431 420 405 394 261 256 265 273 378 379 327 311 303 314 426
-197 -213 -218 -222 -236 -268 -274 -288 -308 -312 -319 -327 -329 -334 -340 -346 -349 -353 -353 -355 -367 -383 -403 -425 -441 -460 -485 -510 -534 -678 -695 -697 -704 -626 -637 -695 -719 -735 -733 -505
21 21 21 21 23 28 30 36 37 40 42 42 42 42 43 45 49 49 51 52 53 53 53 53 53 54 54 54 54 53 52 52 53 58 55 54 54 51 53 53

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?